3.2 C
New York
Wednesday, February 1, 2023

Harpoon Therapeutics Inc. (HARP) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Harpoon Therapeutics Inc. (HARP) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.002, or -0.24%, to $0.83. The Harpoon Therapeutics Inc. has recorded 11,385 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Stocks Info

Harpoon Therapeutics Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.83 and fluctuated between $0.8400 as its day high and $0.8000 as its day low. The current market capitalization of Harpoon Therapeutics Inc. is $26.90M. A total of 0.56 million shares were traded on the day, compared to an average of 2.06M shares.

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, HARP has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for HARP in the last 3 months, the mean price target is $6.81 with high estimates of $16.00 and low estimates of $1.50. In terms of 52-week highs and lows, HARP has a high of $6.30 and a low of $0.59.

As of this writing, HARP has an earnings estimate of -$0.56 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.41 per share and a lower estimate of -$0.81. The company reported an EPS of -$0.62 in the last quarter, which was -14.80% lower than expectations of -$0.54.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HARP is Overweight with a score of 4.50. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 2 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles